Received Mar 19, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | N/A | 72NF3 | IM / LA |
Patient had already received the Boostrix vaccine on April 29, 2025. This vaccine was inappropriately administered, since the patient did not need another Tdap vaccination yet. No adverse reaction reported by the patient as a result of this 2nd vaccination.
None
None